Simulating the Impact of Improved Cardiovascular Risk Interventions on Clinical and Economic Outcomes in Russia

• Kenny Shum ,

  * E-mail: kenny.shum@evidera.com

  Current address: Evidera, Inc., San Francisco, California, United States of America

  Affiliation Archimedes, San Francisco, California, United States of America

  ⨯
• Peter Alperin,

  Current address: Evidera, Inc., San Francisco, California, United States of America

  Affiliation Archimedes, San Francisco, California, United States of America

  ⨯
• Svetlana Shalnova,

  Affiliation National Research Center for Preventive Medicine, Moscow, Russia

  ⨯
• Sergey Boytsov,

  Affiliation National Research Center for Preventive Medicine, Moscow, Russia

  ⨯
• Anna Kontsevaya,

  Affiliation National Research Center for Preventive Medicine, Moscow, Russia

  ⨯
• Alexey Vigdorchik,

  Affiliation Novartis Pharma LLC, Moscow, Russia

  ⨯
• Adam Guetz,

  Current address: Evidera, Inc., San Francisco, California, United States of America

  Affiliation Archimedes, San Francisco, California, United States of America

  ⨯
• Jennifer Eriksson,

  Affiliation OptumInsight Life Sciences, Stockholm, Sweden

  ⨯
• David Hughes

  Affiliation Department of Healthcare Systems, Novartis International AG, Basel, Switzerland

  ⨯